Patents Assigned to GB PHARMA S.R.L.
  • Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes
    Patent number: 11191738
    Abstract: The use of tamoxifen or a pharmaceutically acceptable salt as non estrogen-dependent acting drug for the treatment of cystic fibrosis in patients of both sexes is disclosed. Tamoxifen is preferably administered by inhalation route.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: December 7, 2021
    Assignee: GB PHARMA S.R.L.
    Inventor: Giorgio Balduzzi